The present invention relates to compounds of formula (I):
1
or a pharmaceutically acceptable salt, solvate, hydrate or a pharmaceutically acceptable formulation thereof. Those compounds can be used for inhibiting factor Xa and for the prevention and/or treatment of thromboembolic conditions.
本发明涉及以下式(I)的化合物或其药学上可接受的盐、溶剂化合物、
水合物或药学上可接受的配方。这些化合物可用于抑制Xa因子,并用于预防和/或治疗血栓栓塞性疾病。